Baker Mark Robert - Insider Stock Trading

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	1	1	25	2	3	4	5	24	20	10
P	%wins				76	80	48	48	60	56	61

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
3/28/13 09:24	3/27/13	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	5.32	3	1	0	161	D	-12	-43	61	80	94	57	20	6	0	-7	-11	-18	-4	-26
2/28/13 17:24	2/27/13	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	2.72	0	1	1	160	D	-52	-73	-36	19	-19	-8	-6	-2	6	18	102	52	113	84
1/23/13 09:59	1/22/13	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	2.82	1	1	1	159	D	-53	-70	-73	-13	20	-5	-15	-8	4	5	-4	70	113	142
12/26/12 13:05	12/26/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	3.01	1	1	1	158	D	-39	-66	-66	-10	97	35	37	4	-3	9	-3	80	47	83
11/30/12 12:07	11/28/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	2.13	1	2	1	157	D	-54	-59	-75	-46	-26	14	10	0	4	3	32	26	81	127
11/20/12 13:41	11/19/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	23	1.96	1	12	8	155	D	-54	-67	-73	-51	-24	-30	3	29	10	6	40	33	91	90
11/19/12 13:50	11/16/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	91	1.82	1	50	53	143	D	-59	-70	-76	-58	-33	-36	-31	11	10	22	30	50	116	102
11/16/12 13:54	11/15/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	82	1.69	0	49	109	94	D	-63	-72	-80	-60	-36	-41	-42	12	9	37	38	71	145	126
10/25/12 11:34	10/24/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	2.96	1	1	3	45	D	-40	-55	-73	-73	-22	4	-4	-11	0	-5	-25	2	59	41
9/27/12 15:14	9/26/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	3.32	1	1	2	44	D	-40	-53	-70	-67	-28	-14	-16	-9	-1	-12	-4	-9	78	66
8/23/12 09:44	8/22/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	4.23	3	1	2	43	D	5	-32	-58	-47	-58	-9	-1	0	0	1	-20	-45	-35	24
7/26/12 11:42	7/25/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	10.04	2	0	1	42	D	125	63	7	-5	28	-1	0	0	5	-53	-59	-71	-71	-40
6/29/12 09:15	6/27/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	9.27	2	0	1	41	D	67	27	6	-8	16	8	7	1	7	13	-41	-67	-67	-51
5/24/12 12:38	5/23/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	7.81	1	0	1	41	D	80	12	37	-21	-19	-23	-10	5	2	9	11	-47	-71	-46
4/27/12 09:23	4/25/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	4	10.07	1	0	1	41	D	68	48	69	16	15	11	12	2	3	-5	-22	-2	-73	-57
3/29/12 15:12	3/28/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	10.13	1	0	1	40	D	89	57	55	14	4	10	0	5	0	0	12	-8	-70	-46
2/23/12 09:28	2/22/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	9.41	1	0	1	40	D	104	67	54	56	6	-4	0	-2	5	2	-1	-17	-56	-73
1/26/12 10:05	1/25/12	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	9.53	1	0	1	40	D	107	57	53	45	28	13	11	2	-2	4	6	12	7	-69
1/12/12 13:16	10/26/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P.m	7	7.51	3	1	2	39	D	102	58	16	43	60	5	4	4	0	6	7	10	14	-61
9/28/11 16:55	9/28/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	6.39	1	1	1	37	D	15	27	1	-15	8	12	12	12	-1	7	13	45	64	-44
8/25/11 09:31	8/24/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	6.08	1	1	2	36	D	13	50	9	-17	-18	17	-3	-5	-3	1	-4	-11	63	-32
7/28/11 17:06	7/27/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	6.12	1	1	2	36	D	9	29	-10	-23	-17	-27	-20	-14	-4	4	5	12	65	88
6/24/11 10:07	6/22/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	7.08	1	0	2	32	D	48	29	40	13	-20	-11	-4	-2	0	4	-7	-17	28	27
5/26/11 15:15	5/25/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	7.13	1	0	2	31	D	43	52	56	32	3	0	-9	-2	6	6	-7	-17	-26	9
4/27/11 16:05	4/27/11	PGNX	Progenics Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Baker Mark Robert	NY	DO	CEO	P	3	7.24	1	0	2	31	D	28	16	49	21	28	18	-2	-1	1	5	2	-15	-11	46

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y